Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 1 von 63
Clinical Medicine Insights: Endocrinology and Diabetes, 2022-02, Vol.15, p.11795514221074672-11795514221074672
2022
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Hyperthyroidism and Liver Dysfunction: A Review of a Common Comorbidity
Ist Teil von
  • Clinical Medicine Insights: Endocrinology and Diabetes, 2022-02, Vol.15, p.11795514221074672-11795514221074672
Ort / Verlag
London, England: SAGE Publications
Erscheinungsjahr
2022
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • Deranged liver enzymes due to hyperthyroidism rather than intrinsic liver pathology are not uncommon. The reported prevalence of liver biochemical abnormalities in patients with untreated thyrotoxicosis varies widely ranging from 15% to 76%. The suggested causes of liver dysfunction include direct hepatocyte injury, co-morbid heart failure, associated autoimmune conditions (especially in the setting of Graves’ Disease), preexisting liver disease and drugs including antithyroid medications. Although, some patients may have a pattern of mild liver injury, about 1% to 2% can have fulminant hepatitis. Liver enzymes can return to normalcy in as many as 77% to 83% of patients once the initiations of thionamides are started in a timely fashion, which can help forestall complications and prevent or minimize multi-organ dysfunction. Clinicians should maintain a high index of suspicion for underlying hyperthyroidism in patients presenting with unexplained liver dysfunction or unexplained jaundice.
Sprache
Englisch
Identifikatoren
ISSN: 1179-5514
eISSN: 1179-5514
DOI: 10.1177/11795514221074672
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_ad18b70e8a724572966115eb5220814a

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX